X
Xealth
Enables healthcare teams to order digital content and services as easily as they do orders and medications today
About Xealth
Xealth operates as an integrated digital prescribing and analytics platform, primarily serving healthcare providers such as physicians and care teams. The company operates in the digital health market, offering a solution that allows medical professionals to prescribe digital health content, applications, and services with the same ease as traditional medications. This platform enhances patient education and engagement by extending the patient-physician interaction beyond the examination room. Xealth's business model revolves around providing a subscription-based service to healthcare institutions, which in turn use the platform to improve patient outcomes and streamline care processes. Revenue is generated through these subscriptions and potentially through partnerships with digital health content providers. The platform's analytics capabilities also offer valuable insights into patient engagement and treatment efficacy, further adding value to healthcare providers.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2017
- Headquarters
- Seattle, United States
- Employees
- 65
- Open positions
- None listed
- Dealroom signal
- 74.8/100
- Industry
- Health, Marketing
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Personal Health, Patient Care, Patient Engagement, Health Diagnostics, Hospital Logistics, Tech for Hospitals and Clinics, Hard Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jul 2025 | $0 | — | Samsung Electronics | ↗ |
| GROWTH EQUITY VCOther financing | Mar 2025 | $0 | — | Morningside | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Xealth is 42K monthly website visits, up 75% over the last three months. Xealth's team grew 8.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Providence Health & Services
Froedtert Health
UPMC Enterprises
Threshold Ventures
Hennepin County Medical Center
Series A12 investors entered at this stage
MemorialCare Innovation Fund
Cleveland Clinic- CCCerner Capital
Cerner (Formerly PGI & Associates)
LRVHealth
McKesson Ventures
Trinity Health Company
Philips
ResMed
Novartis
Advocate Aurora Health
Stanford Health Care
Series B and later1 investor entered at this stage
Other known investors1 additional known investor
Samsung Electronics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Xealth on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xealth’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.